Clinical Trial Update: Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma [Phase 2]

View source ↗

Summary

This Phase 2 trial comparing S-1 plus cisplatin (SP) versus gemcitabine plus cisplatin (GP) in metastatic biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Asan Medical Center | Conditions: Metastatic Biliary Cancer | Phase 2 | Status: COMPLETED